Status | Study |
Withdrawn |
Study Name: Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma Condition: Phaeochromocytoma Paraganglioma Date: 2013-09-10 Interventions: Drug: Vandetanib 100 mg, 200 m |
Available |
Study Name: Expanded Access Protocol Using 131I-MIBG Therapy for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma Condition: Neuroblastoma Pheochromocytoma Paraganglioma Date: 2013-04-08 Interventions: Radiation: I-131 MIBG The therapeutic dose (5-18 mCi/kg at investigator's discretion; any dose ≥12 |
Active, not recruiting |
Study Name: Dovitinib in Neuroendocrine Tumors Condition: Advanced Metastatic Paraganglioma Advanced Metastatic Pheochromocytoma Date: 2012-07-05 Interventions: Drug: Dovitinib |
Available |
Study Name: Expanded Access Protocol Using I131-MIBG Condition: Neuroblastoma Pheochromocytoma Paraganglioma Date: 2012-05-01 Interventions: Radiation: I-131 MIBG The therapeutic dose (5-18 mCi/kg at investigator's discretion; any dose ≥12 |
Completed |
Study Name: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors Condition: Carney Complex Chondrosarcoma Gastrointestinal Stromal Tum Date: 2012-03-20 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors Condition: Pheochromocytoma Paraganglioma Date: 2011-08-08 Interventions: Radiation: 131I-MIBG Therapeutic 131I-MIBG will be synthesized at Nuclear Diagnostic Products (NDP; Rock |
Available |
Study Name: Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma Condition: Pheochromocytoma Paraganglioma Date: 2011-06-13 Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG) Therapeutic 131I-MIBG will be synthesized at Nuclear Di |
Available |
Study Name: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors Condition: Pheochromocytoma Neuroblastoma Paraganglioma Date: 2011-06-13 Interventions: Drug: 123I-meta-iodobenzylguanidine |
Recruiting |
Study Name: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma Condition: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL) Date: 2011-06-09 Interventions: Drug: Sunitinib sunitinib 37.5 |
Active, not recruiting |
Study Name: Stereotactic Body Radiotherapy for Spine Tumors Condition: Spinal Metastases Vertebral Metastases Benign Spinal Tumor Date: 2011-05-02 Interventions: Radiation: SBRT for Benign Extradural Spine Tumors |